RhumbLine Advisers’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.33M | Buy |
365,035
+82,969
| +29% | +$302K | ﹤0.01% | 2106 |
|
|
2025
Q1 | $542K | Buy |
282,066
+16,677
| +6% | +$32K | ﹤0.01% | 2526 |
|
|
2024
Q4 | $504K | Buy |
265,389
+22,513
| +9% | +$42.8K | ﹤0.01% | 2674 |
|
|
2024
Q3 | $321K | Sell |
242,876
-4,184
| -2% | -$5.52K | ﹤0.01% | 2986 |
|
|
2024
Q2 | $252K | Buy |
247,060
+242,134
| +4,915% | +$247K | ﹤0.01% | 3094 |
|
|
2024
Q1 | $9.01K | Hold |
4,926
| – | – | ﹤0.01% | 3888 |
|
|
2023
Q4 | $6.11K | Hold |
4,926
| – | – | ﹤0.01% | 3942 |
|
|
2023
Q3 | $5.62K | Hold |
4,926
| – | – | ﹤0.01% | 3961 |
|
|
2023
Q2 | $4.51K | Buy |
+4,926
| New | +$4.51K | ﹤0.01% | 4112 |
|
|
2022
Q2 | – | Sell |
-205,062
| Closed | -$147K | – | 3091 |
|
|
2022
Q1 | $147K | Sell |
205,062
-6,053
| -3% | -$4.34K | ﹤0.01% | 2823 |
|
|
2021
Q4 | $477K | Buy |
211,115
+805
| +0.4% | +$1.82K | ﹤0.01% | 2527 |
|
|
2021
Q3 | $606K | Buy |
210,310
+7,351
| +4% | +$21.2K | ﹤0.01% | 2452 |
|
|
2021
Q2 | $769K | Buy |
202,959
+28,718
| +16% | +$109K | ﹤0.01% | 2361 |
|
|
2021
Q1 | $590K | Sell |
174,241
-14,840
| -8% | -$50.3K | ﹤0.01% | 2408 |
|
|
2020
Q4 | $529K | Buy |
189,081
+13,065
| +7% | +$36.6K | ﹤0.01% | 2420 |
|
|
2020
Q3 | $442K | Sell |
176,016
-33,183
| -16% | -$83.3K | ﹤0.01% | 2341 |
|
|
2020
Q2 | $2.84M | Sell |
209,199
-5,492
| -3% | -$74.6K | ﹤0.01% | 1532 |
|
|
2020
Q1 | $1.63M | Buy |
214,691
+30,789
| +17% | +$233K | ﹤0.01% | 1651 |
|
|
2019
Q4 | $1.16M | Buy |
183,902
+6,644
| +4% | +$42K | ﹤0.01% | 2008 |
|
|
2019
Q3 | $695K | Buy |
177,258
+16,059
| +10% | +$63K | ﹤0.01% | 2203 |
|
|
2019
Q2 | $780K | Buy |
161,199
+48,899
| +44% | +$237K | ﹤0.01% | 2165 |
|
|
2019
Q1 | $920K | Sell |
112,300
-9,097
| -7% | -$74.5K | ﹤0.01% | 2076 |
|
|
2018
Q4 | $671K | Buy |
121,397
+76,163
| +168% | +$421K | ﹤0.01% | 2162 |
|
|
2018
Q3 | $399K | Sell |
45,234
-2,413
| -5% | -$21.3K | ﹤0.01% | 2368 |
|
|
2018
Q2 | $476K | Buy |
47,647
+6,605
| +16% | +$66K | ﹤0.01% | 2327 |
|
|
2018
Q1 | $391K | Buy |
41,042
+270
| +0.7% | +$2.57K | ﹤0.01% | 2317 |
|
|
2017
Q4 | $606K | Sell |
40,772
-3,993
| -9% | -$59.3K | ﹤0.01% | 2162 |
|
|
2017
Q3 | $881K | Buy |
44,765
+3,255
| +8% | +$64.1K | ﹤0.01% | 2036 |
|
|
2017
Q2 | $596K | Buy |
41,510
+518
| +1% | +$7.44K | ﹤0.01% | 2209 |
|
|
2017
Q1 | $377K | Buy |
40,992
+1,266
| +3% | +$11.6K | ﹤0.01% | 2387 |
|
|
2016
Q4 | $414K | Sell |
39,726
-6,815
| -15% | -$71K | ﹤0.01% | 2320 |
|
|
2016
Q3 | $421K | Buy |
46,541
+710
| +2% | +$6.42K | ﹤0.01% | 2300 |
|
|
2016
Q2 | $343K | Buy |
45,831
+923
| +2% | +$6.91K | ﹤0.01% | 2444 |
|
|
2016
Q1 | $405K | Buy |
44,908
+12,110
| +37% | +$109K | ﹤0.01% | 2360 |
|
|
2015
Q4 | $424K | Buy |
32,798
+1,010
| +3% | +$13.1K | ﹤0.01% | 2349 |
|
|
2015
Q3 | $307K | Buy |
31,788
+1,848
| +6% | +$17.8K | ﹤0.01% | 2519 |
|
|
2015
Q2 | $308K | Buy |
+29,940
| New | +$308K | ﹤0.01% | 2636 |
|